Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Primary Care
Published in: BMC Primary Care 1/2021

Open Access 01-12-2021 | Stroke | Research article

Patients’ and clinicians’ perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis

Authors: Yeyenta Mina Osasu, Richard Cooper, Caroline Mitchell

Published in: BMC Primary Care | Issue 1/2021

Login to get access

Abstract

Background

Atrial fibrillation (AF) increases the risk of developing a stroke by 20%. AF related strokes are associated with greater morbidity. Historically, warfarin was the anticoagulant of choice for stroke prevention in patients with AF but lately patients are being switched or started on direct oral anticoagulants (DOACs). DOACs are promoted as safer alternatives to warfarin and it is expected that they will be associated with fewer challenges both for patients and healthcare professionals. This systematic narrative review aimed to explore perspectives of patients and professionals on medicines optimisation of oral anticoagulation with vitamin K antagonists and DOACs in atrial fibrillation.

Methods

Prospero registration CRD42018091591. Systematic searches undertaken of research studies (qualitative and quantitative), published February 2018 to November 2020 from several databases (Web of Science, Scopus, Medline Via Ovid, CINHAL via Ebsco, and PubMED via NCBI) following PRISMA methodology. Data were organised using Covidence software. Two reviewers independently assessed the quality of the included studies and synthesized the findings (thematic analysis approach).

Results

Thirty-four studies were included. Studies were critically appraised using established critical appraisal tools (Qualsyst) and a risk of bias was assigned. Clinicians considered old age and the associated complexities such as co-morbidities and the increased potential for bleeding as potential barriers to optimising anticoagulation. Whereas patients’ health and medication beliefs influenced adherence. Notably, structured patient support was important in enhancing safety and effective anticoagulation. For both patients and clinicians, confidence and experience of safe anticoagulation was influenced by the presence of co-morbidities,  poor knowledge and understanding of AF and the purpose of anticoagulation.

Conclusion

Age, complex multimorbidity and polypharmacy influence prescribing, with DOACs being perceived to be safer than warfarin. This systematic narrative review suggests that interventions are needed to support patient self-management. There are residual anxieties associated with long term anticoagulation in the context of complexities.

Trial registration

Not applicable.
Appendix
Available only for authorised users
Literature
1.
Norberg J, Bäckström S, Jansson JH, Johansson L. Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data. Clin Epidemiol. 2013;5(1):475–81.PubMedPubMedCentral
2.
Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey. Chest. 2010;138(5):1093–100.PubMed
3.
4.
5.
6.
Eckman MH, Lip GYH, Wise RE, Speer B, Sullivan M, Walker N, et al. Impact of an atrial fibrillation decision support tool on thromboprophylaxis for atrial fibrillation. Am Heart J. 2016;176:17–27.PubMed
7.
Renoux C, Loo SY, Dell’aniello S, Huiart L. PHARMACOEPIDEMIOLOGY trends in the prescription of novel oral anticoagulants in UK primary care. Br J Clin Pharmacol. 2017;83(9):2096-106.
8.
Hanemaaijer S, Sodihardjo F, Horikx A, Wensing M, De Smet PAGM, Bouvy ML, et al. Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands. Int J Clin Pharm. 2015;37(6):1128–35.PubMedPubMedCentral
9.
Brown JD, Shewale AR, Dherange P, Talbert JC. A comparison of Oral anticoagulant use for atrial fibrillation in the pre- and post-DOAC eras. Drugs Aging. 2016;33(6):427–36.PubMed
10.
11.
12.
Kennedy C, Ni Choitir C, Clarke S, Bennett K, Barry M. Direct oral anticoagulants uptake and an oral anticoagulation paradox. Br J Clin Pharmacol. 2020;86(2):392–7.PubMedPubMedCentral
13.
Generalova D, Cunningham S, Leslie SJ, Rushworth GF, McIver L, Stewart D. A systematic review of clinicians’ views and experiences of direct-acting oral anticoagulants in the management of nonvalvular atrial fibrillation. Br J Clin Pharmacol. 2018;84(12):2692–703.PubMedPubMedCentral
14.
NHS England. Medicines optimisation. Medicines: improving outcomes and value. 2018.
15.
Sandelowski M, Voils C, Barroso J. Defining and designing mixed research synthesis studies. Res Sch. 2006;13(1):29–40.PubMedPubMedCentral
16.
Pope C, Mays N, Popay J. Synthesizing qualitative and quantitative health evidence. A guide to methods. In: Synthesizing qualitative and quantitative health evidence a guide to methods. 1st ed. Maidenhead: McGraw Hill; 2007. p. 29.
17.
Kmet LM, Lee RC, Cook LS. HTA initiative # 13. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Alberta: Alberta Heritage Foundation for Medical Research; 2004.
18.
19.
Monette J, Gurwitz JH, Rochon PA, Avorn J. Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc. 1997;45(9):1060–5.PubMed
20.
Lip GYH, Kamath S, Jafri M, Mohammed A, Bareford D. Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham atrial fibrillation project. Stroke. 2002;33(1):238–42.PubMed
21.
Mccrory C, Matchar DB, Samsa G, Sanders LL, Pritchett ELC. Physiscian attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med. 1995;155:277–81.PubMed
22.
23.
24.
25.
Alonso-Coello P, Montori VM, Diaz MG, Devereaux PJ, Mas G, Diez AI, et al. Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: Physician and patient perspectives. Heal Expect. 2015;18(6):2318–27.
26.
Gross CP, Vogel EW, Dhond AJ, Marple CB, Edwards RA, Hauch O, et al. Factors influencing physicians’ reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey. Clin Ther. 2003;25(6):1750–64.PubMed
27.
Rewiuk K, Bednarz S, Faryan P, Grodzicki T. Knowledge of antithrombotic prophylaxis among patients with atrial fibrillation. Folia Cardiol. 2007;14(1):44–9.
28.
29.
30.
31.
32.
33.
Frankel DS, Parker SE, Rosenfeld LE, Gorelick PB. HRS/NSA 2014 survey of atrial fibrillation and stroke: gaps in knowledge and perspective, opportunities for improvement. J Stroke Cerebrovasc Dis. 2015;24(8):1691–700.PubMed
34.
35.
36.
Ikeda T, Yasaka M, Kida M, Imura M. A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study. Patient Prefer Adherence. 2018;12:135–43.PubMedPubMedCentral
37.
Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives. J Clin Nurs. 2017;26:4325–34 [cited 2017 Aug 7]. Available from: http://​doi.​wiley.​com/​10.​1111/​jocn.​13759.PubMed
38.
39.
Alonso-Coello P, Montori VM, Diaz MG, Devereaux PJ, Mas G, Diez AI, et al. Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives. Health Expect. 2015;18(6):2318–27.PubMed
40.
Glauser TA, Barnes J, Nevins H, Cerenzia W. The educational needs of clinicians regarding anticoagulation therapy for prevention of thromboembolism and stroke in patients with atrial fibrillation. Am J Med Qual. 2016;31(1):38–46.PubMed
41.
42.
43.
Murphy A, Kirby A, Bradley C. Monitoring of atrial fibrillation in primary care patients prescribed direct oral anticoagulants for stroke prevention. Ir J Med Sci. 2020;189(3):961–6.PubMed
44.
45.
Bartoli-Abdou JK, Patel JP, Xie R, Dzahini O, Vadher B, Brown A, et al. Associations between illness beliefs, medication beliefs, anticoagulation-related quality of life, and INR control: insights from the switching study. Res Pract Thromb Haemost. 2018;2(3):497–507.PubMedPubMedCentral
46.
47.
48.
Bajorek BV, Ogle SJ, Duguid MJ, Shenfield GM, Krass I. Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers. Med J Aust. 2007;186(4):175–80.PubMed
49.
50.
Bartoli-Abdou JK, Patel JP, Crawshaw J, Vadher B, Brown A, Roberts LN, et al. Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study. Thromb Res. 2018;162(January):62–8.PubMed
51.
52.
Bajorek BV, Ogle SJ, Duguid MJ, Shenfield GM, Krass I. Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy. Pharm Pract (Granada). 2009;7(2):113–23.
53.
McGrath ER, Go AS, Chang Y, Borowsky LH, Fang MC, Reynolds K, et al. Use of oral anticoagulant therapy in older adults with atrial fibrillation after acute ischemic stroke. J Am Geriatr Soc. 2017;65(2):241–8.PubMed
54.
55.
Ferguson C, Inglis SC, Newton PJ. Multi-morbidity, frailty and self-care: important considerations in treatment with anticoagulation drugs. Outcomes of the AFASTER study. Eur J Cardiovasc Nurs. 2017;16(2):113–24.PubMed
56.
57.
Borg Xuereb C, Shaw RL, Lane DA, Xuereb CB, Shaw RL, Lane DA. Patients’ and health professionals’ views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis. Patient Educ Couns. 2012;88:330–7.PubMed
58.
59.
Clarkesmith DE, Pattison HM, Lip GYH, Lane DA. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial. PLoS One. 2013;8(9):e74037 Available from: anticoagulation, atrial fibrillation, patient education.PubMedPubMedCentral
60.
Britten N, Maguire K. Lay knowledge, social movements and the use of medicines: personal reflections. Heal (United Kingdom). 2016;20(2):77–93.
61.
62.
Gorst-Rasmussen A, Skjoth F, Larsen TB, Rasmussen LH, Lip GYH, Lane DA. Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study. J Thromb Haemost. 2015;13(4):495–504.PubMed
63.
Clyne B, Cooper JA, Boland F, Hughes CM, Fahey T, Smith SM. Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care. Br J Gen Pract. 2017;67(660):e507–18.PubMedPubMedCentral
Metadata
Title
Patients’ and clinicians’ perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis
Authors
Yeyenta Mina Osasu
Richard Cooper
Caroline Mitchell
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2021
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/s12875-021-01590-x

Other articles of this Issue 1/2021

BMC Primary Care 1/2021 Go to the issue

Research

Beliefs and practices among primary care physicians during the first wave of the COVID-19 pandemic in Baden-Wuerttemberg (Germany): an observational study

Research article

A qualitative inquiry of access to and quality of primary healthcare in seven communities in East and West Africa (SevenCEWA): perspectives of stakeholders, healthcare providers and users

Research

A qualitative exploration of nursing undergraduates’ perceptions towards scaffolding in the flipped classroom of the Fundamental Nursing Practice Course: a qualitative study

Research

“She knows me best”: a qualitative study of patient and caregiver views on the role of the primary care physician follow-up post-hospital discharge in individuals admitted with chronic obstructive pulmonary disease or congestive heart failure

Research

A pilot study of participatory and rapid implementation approaches to increase depression screening in primary care

Research article

Implementation outcomes of Humanwide: integrated precision health in team-based family practice primary care